MyFinsight
Home
Blog
About
Contact
Download
Download image
Interest income, net
$15,953K
Net loss
-$154,651K
Total other income,
net
$15,953K
Loss from operations
-$170,604K
Total operating
expenses
$170,604K
Research and development
$132,009K
General and
administrative
$38,595K
Back
Back
Income Statement
source: myfinsight.com
Mineralys Therapeutics, Inc. (MLYS)
Mineralys Therapeutics, Inc. (MLYS)